Complex Percutaneous Coronary Intervention: Discrete Entity or Just Another Subgroup to Analyze?

Affiliations

¹ Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha (A.M.G.).
² Division of Cardiovascular Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (T.J.P.).

Editorial

Andrew M Goldsweig et al. Circ Cardiovasc Interv. 2021 Jul.

. 2021 Jul;14(7):e010891.

doi: 10.1161/CIRCINTERVENTIONS.121.010891. Epub 2021 Jun 16.

¹ Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha (A.M.G.).
² Division of Cardiovascular Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (T.J.P.).

No abstract available

Keywords: Editorials; heart failure; prasugrel hydrochloride; risk factors; ticagrelor.

Comment on

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention.
Coughlan JJ, Aytekin A, Ndrepepa G, Schüpke S, Bernlochner I, Mayer K, Neumann FJ, Menichelli M, Richardt G, Wöhrle J, Witzenbichler B, Gewalt S, Xhepa E, Kufner S, Sager HB, Joner M, Ibrahim T, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A, Cassese S. Coughlan JJ, et al. Circ Cardiovasc Interv. 2021 Jul;14(7):e010565. doi: 10.1161/CIRCINTERVENTIONS.121.010565. Epub 2021 Jun 16. Circ Cardiovasc Interv. 2021. PMID: 34130477